Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02001337 · ClinicalTrials.gov registry record
Examination of the Pancreas in New-onset Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 79
- Enrollment target
NCT02001337: Completed study, sponsored by Mayo Clinic.
NCT02001337 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02001337 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
Interventions
- OTHER medical chart review
- OTHER Specimen collection
- OTHER survey administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02001337
The ClinicalTrials.gov registry entry for NCT02001337 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT02001337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02001337 about?
NCT02001337 is a clinical study titled "Examination of the Pancreas in New-onset Diabetes". The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
What is the current status of trial NCT02001337?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2013-05. Estimated completion is 2016-11-30.
What interventions are being tested in trial NCT02001337?
The interventions under investigation include: medical chart review (OTHER), Specimen collection (OTHER), survey administration (OTHER).
Who is sponsoring clinical trial NCT02001337?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.